Publications » Search Results » 2001 » Other publications

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Show per page  
11Zablotskaya A.; Segal I.; Germane S.; Lukevics E.; Spies H. Psychotropic activity of O-organosilicon containing 3-thia, 3-oxa and 3-methylazapentane-1,5-dithiolato-oxorhenium(V). Annual Report 2000: Institute of Bioinorganic and Radiopharmaceutical chemistry. FZR-312, January . 2001, 66-67.      

12Vosekalna I.; Gyurcsik B.; Larsen E. Solution structure of oligopeptides-copper(II) complexes by CD spectroscop. Peptides 2000: Proceeding of the 26th European Peptide symposium, September 10-15, 2000, Montpellier, France (Eds. J.Martinez, J.-A.Fehrentz, EDK, Paris). 2001, 543-544.      

13Stonkus V.; Leite L.; Lebedev A.; Lukevics E.; Ruplis A.; Stoch J.; Mikolajczyk M. Structure and catalytic properties of Co/porcelain in the synthesis of 2,3-dihydrofuran. J. Chem. Technol. Biotechnol. 2001, 76, 101-105.      

14Sjakste N.; Sjakste T. Genomic domains of globin genes in mammals:[a review]. Balt. J. Lab. Anim. Sci. 2001, 11, 23-33.      

15Ponomarenko E.; Pokrotnieks J.; Jirgensons A.; Seleznevs J.; Danilans A.; Shubnikova N.; Kalvins I. I. Modulation of Na, K-ATPase activity by immunoglobulins. III. Influence of an ATPase activity regulating agent Marina on Na, K-ATPase activity in patients with various chronic disturbances. Chin. Med. J. (Taipei). 2001, 64(11), 617-620.      

16Ponomarenko E.; Pletneva T.; Kalvins I. Modulation of Na, K-ATPase activity by immunoglobulins. I. Effects of IgM on the Na, K-ATPase activity in glomerulonephritis . Chin. Med. J. (Taipei). 2001, 64(9), 493-500.      

17Ponomarenko E.; Maslova M.; Orlikovs G.; Seleznevs J.; Pokrotnieks J.; Danilans A.; Reinholds E.; Farbtuha T.; Kalvins I. I. Modulation of Na,K-ATPase activity by immunoglobulins. II. Na,K-ATPase activity in erythrocytes from patients with various chronic disturbances. Chin. Med. J. (Taipei). 2001, 64(10), 563-567.      

18Vosekalna I.; Gyurcsik B.; Larsen E. Solution structure of oligopeptides-copper(II) complexes. Peptides: The Wave of the Future. Eds. M. Lebl, R.A. Houghten. Proc. of the 2nd Intern. & 17th Amer. Peptide symp., June 9-14, San Diego, California, USA . 2001, 306-307.      

19Roumelioti P.; Polevaya L.; Giatas N.; Zoga A.; Mutule I.; Keivish T.; Mavromoustakos T.; Zoumpoulakis P.; Vlahakos D.; Matsoukas J. Design and synthesis of an amide-linked angiotensin II analogue with 3,5 side-chain bridge: structural resemblance of ring cluster conformation with AT1 non-peptide antagonists. Peptides: The Wave of the Future. Eds. M. Lebl, R.A. Houghten. Proc. of the 2nd Intern. & 17th Amer. Peptide symp., June 9-14, San Diego, California, USA . 2001, 656-657.      

20Liepina I.; Czaplewski C.; Janmey P.; Liwo A. Electrostatic and hydrophobic nature of the binding of Gelsolin 135-142 and Gelsolin 150-169 fragments to the PIP2-containing lipid bilayer. Peptides: The Wave of the Future. Eds. M. Lebl, R.A. Houghten. Proc. of the 2nd Intern. & 17th Amer. Peptide symp., June 9-14, San Diego, California, USA . 2001, 420-421.      

Show per page